Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since May 29 · below the Ichimoku cloud · RSI 44 · MACD below its signal
None of the 29 investors followed here reported a position in CTMCF in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a CTMCF trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -19.9 | 8.9 | -8.0 | 19.2 | -21.4 | -14.7 | -16.2 | 9.4 | -2.1 | -5.5 | −45.5% | ||
| 2025 | -27.4 | 3.7 | 3.6 | -7.5 | 11.7 | 10.8 | 2.0 | 39.4 | 14.2 | 9.5 | 22.2 | 17.1 | +126.9% |
| 2024 | -15.3 | -28.8 | 34.5 | 8.2 | -12.9 | -21.6 | -15.3 | 2.6 | -0.8 | 2.9 | 131.1 | -14.1 | +5.4% |
| 2023 | 6.1 | 14.3 | -14.0 | 22.1 | 11.7 | -2.8 | 15.1 | -12.4 | 6.5 | -12.2 | -2.0 | 60.9 | +105.5% |
| 2022 | -23.8 | 39.4 | -11.4 | -14.0 | -24.0 | -44.1 | 11.8 | -25.7 | 0.8 | -46.3 | -22.2 | 30.4 | −84.3% |
| 2021 | 1.7 | 24.5 | -18.0 | -26.7 | -0.3 | 51.4 | -28.0 | 38.7 | -16.1 | -13.2 | -10.4 | 3.9 | −22.4% |
| 2020 | 0.0 | 126.7 | 172.9 | -64.0 | -64.0 | 277.6 | 74.1 | -17.9 | -3.7 | -7.9 | 0.0 | 134.7 | +801.7% |
| 2019 | -16.7 | 15.1 | 0.0 | 0.0 | -13.1 | 0.0 | 30.0 | 0.2 | -7.9 | 25.0 | -53.2 | -57.3 | −75.0% |
| 2018 | 0.0 | -16.2 | 15.2 | -60.0 | 71.9 | 76.8 | -53.9 | -14.3 | 25.0 | -32.0 | -2.0 | 20.0 | −53.7% |
| 2017 | 100.0 | 65.0 | -10.0 | -19.2 | -1.7 | 0.0 | -11.0 | 0.0 | 26.7 | -35.0 | -42.2 | 159.0 | +159.0% |
| 2016 | -31.8 | 0.0 | 40.0 | 18.6 | 11.2 | 6.5 | 147.8 | -23.4 | -16.4 | -6.6 | -45.1 | -58.3 | −54.5% |
| 2015 | -14.5 | 17.6 | -27.1 | 30.0 | 11.7 | -24.6 | -23.3 | 2.8 | -13.8 | -20.1 | -12.0 | 0.0 | −61.6% |
| 2014 | 74.4 | -28.3 | 7.0 | 31.8 | 6.4 | 6.7 | 73.4 | -16.4 | -8.4 | -28.2 | 0.0 | -6.1 | +79.1% |
| 2013 | 76.7 | -15.8 | 7.0 | -39.7 | 1.7 | -15.0 | -4.8 | 0.0 | 8.2 | 0.0 | -7.6 | -5.9 | −25.6% |
| 2012 | 11.8 | 13.0 | -18.3 | -17.0 | -27.9 | -33.0 | 8.5 | -21.9 | 46.0 | 31.5 | -32.3 | -33.8 | −69.8% |
| 2011 | -14.1 | 20.9 | -41.6 | -3.0 | -9.9 | -23.1 | 20.0 | -25.0 | -0.7 | 12.5 | 31.1 | -19.9 | −57.0% |
| 2010 | 977.4 | -33.4 | 17.3 | -3.0 | -34.2 | -8.5 | 7.1 | 9.1 | 43.9 | 31.8 | -15.8 | 57.3 | +1341.3% |
| 2009 | -23.3 | 0.0 | −23.3% |
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 10, 2026 | Farncomb (Andrew)Director of Issuer | Acquisition in the public market at price 0.09 per share. | 50K | $4.50K |
| Jun 25, 2026 | Farncomb (Andrew)Director of Issuer | Exercise of warrants at price 0.06 per share. | 875K | $55.13K |
| Jun 17, 2026 | Serfass (Joshua)Director of Issuer | Exercise of warrants at price 0.06 per share. | 83.3K | $5.33K |
| Jun 9, 2026 | Pennimpede (Christopher Paul)Director of Issuer | Acquisition in the public market at price 0.09 per share. | 50K | $4.50K |
| Jun 8, 2026 | Pennimpede (Christopher Paul)Director of Issuer | Acquisition in the public market at price 0.10 per share. | 12K | $1.16K |
| Mar 1, 2026 | Hills (Sara)Senior Officer of Issuer | Disposition in the public market at price 0.15 per share. | 6K | $873 |
| Mar 1, 2026 | Pennimpede (Christopher Paul)Director of Issuer | Disposition in the public market at price 0.15 per share. | 143.1K | $20.90K |
| Feb 19, 2026 | Hills (Sara)Senior Officer of Issuer | Exercise of rights at price 0.13 per share. | 15.6K | $2.06K |
| Feb 19, 2026 | Pennimpede (Christopher Paul)Director of Issuer | Exercise of rights at price 0.13 per share. | 312.5K | $41.25K |
| Feb 3, 2026 | Manson (Matthew Lamont)Director of Issuer | — | 0 | — |
| Oct 27, 2025 | Farncomb (Andrew)Director of Issuer | Acquisition under a prospectus exemption at price 0.09 per share. | 1.29M | $111.37K |
No analyst coverage for this instrument.
Canterra Minerals Corporation, a resource exploration company, engages in the acquisition, exploration, and evaluation of mineral properties in Canada. The company explores for critical and precious metals, zinc, lead, copper, silver, and gold volcanogenic massive sulphide deposits. Its main projects include the 100%-owned Buchans critical minerals project, which covers 95 square kilometers of mineral claims and mining leases located near the town of Buchans in Newfoundland's Central Mining District; and the 100%-owned Wilding gold project, which comprises the Wilding, Noel Paul, Crystal Lake, and Clipper Brook blocks covering 417 square kilometers located on trend with Equinox Gold's Valentine mine in the Province of Newfoundland. The company was formerly known as Diamondex Resources Ltd. and changed its name to Canterra Minerals Corporation in December 2009. Canterra Minerals Corporation was incorporated in 1999 and is headquartered in Vancouver, Canada.